Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety

Maturitas

Volumn 39, Issue 2, 2001, Pages 185-188

  De Leo, Vincenzo ^a   La Marca, Antonio ^a   Morgante, Giuseppe ^a   Lanzetta, Danila ^a   Florio, Pasquale ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Hormone replacement therapy; Kava extract; Menopausal anxiety

Indexed keywords

ESTRADIOL; KAWAIN; NOMEGESTROL ACETATE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MENOPAUSE; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANXIETY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; KAVA; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; TREATMENT OUTCOME;

PIPER METHYSTICUM;

EID: 0035949164     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00197-9     Document Type: Article

References (13)

1. Contemporary therapy of the menopausal syndrome
2. Oestrogens and depression
3. The climateric syndrome
4. The efficacy of cavain in patients suffering from anxiety
5. Kava-Kava extract WS1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial
6. The assessment of anxiety states by rating
7. Neuroendocrinology of menopausal flushes: An hypothesis of flush mechanism
8. Alternative terapeutiche neuroendocrine
9. Subcutaneous hormone implants for control of climateric symptoms
10. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study
11. Kava: An overview
12. Analysis of kava resin by gas chromatography, electron impact and methane negative ion chemical ionisation mass spectrometry: New trace constituents of kava resin
13. Effects of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats